Levocetirizine as treatment for symptoms of seasonal allergic rhinitis

B-ENT

Volumn 2, Issue 2, 2006, Pages 55-62

  Jorissen, M ^a   Bertrand, B ^b   Stiels, B ^c   Vandenbulcke, K ^d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UCB PHARMA   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Efficacy; Levocetirizine; Safety; Seasonal allergic rhinitis

Indexed keywords

CETIRIZINE; DESLORATADINE; LEVOCETIRIZINE; LORATADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PIPERAZINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HAY FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NASAL PRURITUS; OCULAR PRURITUS; RHINORRHEA; SNEEZING; SOMNOLENCE; XEROSTOMIA; ADOLESCENT; ADULT; AGED; MIDDLE AGED; PATIENT SATISFACTION;

ADOLESCENT; ADULT; AGED; CETIRIZINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; PIPERAZINES; RHINITIS, ALLERGIC, SEASONAL;

EID: 34948835158     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147-334.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Resp J. 2004;24:758-764.
3. Bousquet J. Is the impairment of quality of life acceptable for the patient? Clin Exp Allergy. 2002;32:1-5.
4. de Blic J., Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005;16:267-275.
5. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces cost in long-term management of persistent allergic rhinitis J Allergy Clin Immunol. 2004;114:838-844.
6. Bousquet J, Lund VJ, van Cauwenberge P, et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy. 2003;58:733-741.
7. Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy. 2001;56:985-988.
8. Devalia JL, De Vos C, Hanotte F, Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy. 2001;56:50-57.
9. Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol. 2002;88:190-197.
10. Michel L, Jean-Louis F, Dubertret L. Pharmacological study of levocetirizine in IgE-dependent hypersensitivity cutaneous reaction in grass pollen allergic volunteers: Demonstration of mediator release and eosinophil recruitment modulation by levocetirizine. Allergy. 2001;68:56.
11. Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil trans-endothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy. 2002;32:1187-1192.
12. Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract. 2004;58,2:109-118.
13. Potter PC; Study Group. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy. 2003;58:893-899.
14. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin Exp Allergy. 2004;34:958-964.
15. Katon W. Improvement of outcomes in chronic illness. Arch Fam Med. 2000;9:709-711.
16. Ayres JG, Frost CD, Holmes WF, Williams DR, Ward SM. Post-marketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicine guidelines. BMJ. 1998;317:926-930.
17. Waller PC. Guidelines for company-sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines. Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993). Br J Clin Pharmac. 1994;38:95-97.
18. Li JT, Sheeler RD, Offord KP, Patel AM, Dupras DM. Consultation for asthma: results of a generalist survey. Ann Allergy Asthma Immunol. 1999;83:203-206.
19. Leynadier F, Mees K, Arendt C, Pinelli ME. Efficacy and safety of levocetirizine in seasonal allergic rhinitis. Acta Otorhinolaryngol Belg. 2001;55:305-312.
20. Purohit A, Melac M, Pauli G, Frossard N. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol. 2003;56:388-394.
21. 1 activity of levocetirizine measured by thermography is superior to fexofenadine. In: abstracts of the XXIII EAACI Congress; June 12-16, 2004; Amsterdam. Abstract A248.
22. Larbig M, Stamm H, Hohfeld J, Krug N. Levocetirizine but not desloratadine inhibits histamine-induced changes of nasal temperature measured by facial thermography: a pilot study Allergy. 2003;58:283.
23. Stübner P, Zieglmayer R, Horak F. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomized, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC). Curr Med Res Opin. 2004;20:891-902.
24. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol. 2002;54:51-58.
25. Hindmarch I, Johnson S, Meadows R, Kirkpatrick T, Shamsi Z. The acute and Sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Curr Med Res Opin. 2001;17:241-255.
26. Verster JC, Volkerts ER. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004;92: 294-303; quiz 303-5, 355.
27. Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104:927-933.